Flaujeac factor deficiency. Reconstitution with highly purified bovine high molecular weight-kininogen and delineation of a new permeability-enhancing peptide released by plasma kallikrein from bovine high molecular weight-kininogen
- PMID: 993350
- PMCID: PMC333311
- DOI: 10.1172/JCI108595
Flaujeac factor deficiency. Reconstitution with highly purified bovine high molecular weight-kininogen and delineation of a new permeability-enhancing peptide released by plasma kallikrein from bovine high molecular weight-kininogen
Abstract
Flaujeac trait is the functional deficiency of a plasma protein of the intrinsic coagulation, kinin-forming, and plasma fibrinolytic pathways. The Flaujeac factor in man has been isolated and tentatively identified as a kininogen of high molecular weight (HMW). Highly purified bovine HMW-kininogen, but not bovine low molecular weight kininogen, repaired Flaujeac factor deficiency. The two subspecies of this molecule, HMW-kininogen a and HMW-kininogen b, also corrected Flaujeac factor deficiency. When bovine HMW-kininogen was incubated with bovine plasma kallikrein, kinin-free HMW-kininogen, bradykinin, and a glycopeptide fragment (peptide 1-2; 12,584 daltons) were rapidly released. None of these fragmentation products corrected Flaujeac factor deficiency alone or in mixtures. The function of HMW-kininogen appeared to depend upon the structural integrity of the native molecule. When injected in concentrations of 2 pmol-8 nmol/0.1 ml, peptide 1-2 caused increased vascular permeability in rabbits, rats, or guinea pigs. The enhanced permeability was maximal within 1-2 min and terminated in 5-10 min, differing from that of bradykinin or histamine. Injected together in equimolar amounts, peptide 1-2 and bradykinin produced a synergistic permeability response which was immediate in onset as well as prolonged in duration. Peptide 1-2 is a rapidly acting, highly basic glyco-peptide which mediates increased vascular permeability in a complementary and synergistic manner with bradykinin.
Similar articles
-
Flaujeac trait. Deficiency of human plasma kininogen.J Clin Invest. 1975 Dec;56(6):1663-72. doi: 10.1172/JCI108248. J Clin Invest. 1975. PMID: 127805 Free PMC article.
-
Potentiation of the function of Hageman factor fragments by high molecular weight kininogen.J Clin Invest. 1977 Jul;60(1):7-17. doi: 10.1172/JCI108770. J Clin Invest. 1977. PMID: 874091 Free PMC article.
-
Purification of high molecular weight kininogen and the role of this agent in blood coagulation.J Clin Invest. 1977 Sep;60(3):584-94. doi: 10.1172/JCI108810. J Clin Invest. 1977. PMID: 893664 Free PMC article.
-
The role of Hageman factor, prekallifrein, and high molecular weight kininogen in the generation of bradykinin and the initiation of coagulation and fibrinolysis.Monogr Allergy. 1977;12:120-30. Monogr Allergy. 1977. PMID: 335210 Review. No abstract available.
-
High Molecular Weight Kininogen: A Review of the Structural Literature.Int J Mol Sci. 2021 Dec 13;22(24):13370. doi: 10.3390/ijms222413370. Int J Mol Sci. 2021. PMID: 34948166 Free PMC article. Review.
Cited by
-
Characterization of human high molecular weight kininogen. Procoagulant activity associated with the light chain of kinin-free high molecular weight kininogen.J Exp Med. 1978 Feb 1;147(2):488-99. doi: 10.1084/jem.147.2.488. J Exp Med. 1978. PMID: 75240 Free PMC article.
-
Relation between structure and correcting activity of bovine high molecular weight kininogen upon the clotting time of Fitzgerald-trait plasma.J Exp Med. 1979 Apr 1;149(4):847-55. doi: 10.1084/jem.149.4.847. J Exp Med. 1979. PMID: 429963 Free PMC article.
-
Turnover of human and monkey plasma kininogens in rhesus monkeys.J Clin Invest. 1979 Jan;63(1):45-52. doi: 10.1172/JCI109276. J Clin Invest. 1979. PMID: 105015 Free PMC article.
-
Kinetic analysis of the interaction of human tissue kallikrein with single-chain human high and low molecular weight kininogens.Proc Natl Acad Sci U S A. 1983 Jul;80(13):3928-32. doi: 10.1073/pnas.80.13.3928. Proc Natl Acad Sci U S A. 1983. PMID: 6575386 Free PMC article.
-
Blood Clotting and the Pathogenesis of Types I and II Hereditary Angioedema.Clin Rev Allergy Immunol. 2021 Jun;60(3):348-356. doi: 10.1007/s12016-021-08837-6. Epub 2021 May 6. Clin Rev Allergy Immunol. 2021. PMID: 33956309 Free PMC article. Review.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources